The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds

PloS One
Daniel C Baumgart, Marie le Claire

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) challenge economies worldwide. Detailed health economic data of DRG based academic inpatient care for inflammatory bowel disease (IBD) patients in Europe is unavailable. IBD was identified through ICD-10 K50 and K51 code groups. We took an actual costing approach, compared expenditures to G-DRG and non-DRG proceeds and performed detailed cost center and type accounting to identify coverage determinants. Of all 3093 hospitalized cases at our department, 164 were CD and 157 UC inpatients in 2012. On average, they were 44.1 (CD 44.9 UC 43.3 all 58) years old, stayed 10.1 (CD 11.8 UC 8.4 vs. all 8) days, carried 5.8 (CD 6.4 UC 5.2 vs. all 6.8) secondary diagnoses, received 7.4 (CD 7.7 UC 7 vs. all 6.2) procedures, had a higher cost weight (CD 2.8 UC 2.4 vs. all 1.6) and required more intense nursing. Their care was more costly (means: total cost IBD 8477€ CD 9051€ UC 7903€ vs. all 5078€). However, expenditures were not fully recovered by DRG proceeds (means: IBD 7413€, CD 8441€, UC 6384€ vs all 4758€). We discovered substantial disease specific mismatches in cost centers and types and identified the medical ward personnel and materials budgets to be most imbalanced. Non-DRG proceeds ...Continue Reading

References

Mar 10, 2000·The American Journal of Gastroenterology·C N BernsteinJ F Blanchard
Sep 13, 2002·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Forough FarrokhyarE Jan Irvine
Jul 3, 2004·Health Services Research·Colin Preyra
Sep 17, 2008·European Journal of Gastroenterology & Hepatology·Claudia OttAntje Timmer
Nov 4, 2011·The New England Journal of Medicine·Silvio Danese, Claudio Fiocchi
Nov 24, 2011·Inflammatory Bowel Diseases·Charles N BernsteinJames F Blanchard
Dec 14, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David Scheller-KreinsenReinhard Busse
Aug 24, 2012·Lancet·Daniel C Baumgart, William J Sandborn
Nov 9, 2012·Gut·Mirthe Emilie van der ValkUNKNOWN COIN study group and the Dutch Initiative on Crohn and Colitis
Jun 12, 2013·BMJ : British Medical Journal·Reinhard BusseWilm Quentin

❮ Previous
Next ❯

Citations

Aug 2, 2017·Journal of Medical Economics·Thomas R EinarsonPieter J T Dries
Mar 16, 2017·Journal of Orofacial Orthopedics = Fortschritte Der Kieferorthopädie : Organ/official Journal Deutsche Gesellschaft Für Kieferorthopädie·Julia von BremenSabine Ruf
Apr 16, 2019·Frontiers in Pharmacology·Daniel C BaumgartPeter C Taylor
Sep 2, 2020·Zeitschrift für Gastroenterologie·Marie-Therese Schnorbach, Wolfgang Kruis
Apr 3, 2016·Alimentary Pharmacology & Therapeutics·D C BaumgartUNKNOWN Vedolizumab Germany Consortium

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Software Mentioned

SAP NetWeaver Business Intelligence
grouper

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Journal of Internal Medicine
M El-SalhyL Grimelius
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
Angela RocchiSubrata Ghosh
© 2022 Meta ULC. All rights reserved